Basal levels of CD34 positive cells in peripheral blood differ between individuals and are stable for 18 months

Cytometry Part B - Clinical Cytometry

Volumn 82 B, Issue 1, 2012, Pages 18-25

  Eidenschink, Lisa ^a   Dizerega, Gere ^b   Rodgers, Kathy ^b   Bartlett, Mark ^c   Wells, Denise A ^a   Loken, Michael R ^a  

^a HEMATOLOGICS INC   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Pharmanex   (United States)

Author keywords

CD34; flow cytometry; G CSF; kinetics; progenitor cell enumeration

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; HLA DR ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CD34 PROGENITOR CELL; CELL MOTILITY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUALITY CONTROL; STEM CELL;

ADOLESCENT; ADULT; ANTIGENS, CD34; BLOOD CELL COUNT; BLOOD PRESERVATION; CELL COUNT; FEMALE; GENETIC VARIATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; KINETICS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; TIME FACTORS; YOUNG ADULT;

EID: 84155164732     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20611     Document Type: Article

References (29)

1. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I,. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996; 5: 213-226.
2. Gratama JW, Braakman E, Kraan J, Lankheet P, Levering WH, Van Den Beemd MW, Van Der Schoot CE, Wijermans P, Preijers F,. Comparison of single and dual-platform assay formats for CD34+ haematopoietic progenitor cell enumeration. Clin Lab Haematol 1999; 5: 337-346. (Pubitemid 30007095)
3. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR,. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering 1998. Cytometry 1998; 34: 61-70.
4. Barnett D, Granger V, Kraan J, Whitby L, Reilly JT, Papa S, Gratama JW,. Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training. DK34 Task Force of the European Working Group of Clinical Cell Analysis (EWGCCA). Br J Haematol 2000; 108: 784-92. (Pubitemid 30304511)
5. Gratama JW, Kraan J, Keeney M, Sutherland, DR, Granger V, Barnett D,. Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem cell and progenitor cell enumeration in an international multicenter study. Cytotherapy 2003; 5: 55-65. (Pubitemid 36382936)
6. Moretti S, Dabusti M, Castagnari B, Tieghi A, Ferrai L, Campioni D, Punturieri M, Castoldi GL, Lanza F,. Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: Correlation with colony assays. Int J Biol Markers 2002; 4: 259-267. (Pubitemid 36104341)
7. Levering WH, Preijers FW, van Wieringen WN, Kraan J, Van beers WA, Sintnicolaas K, van Rhenen DJ, Gratama JW,. Flow cytometric CD34+ stem cell enumeration: Lessons from nine years' external quality assessment within the Benelux countries. Cytometry Part B 2007; 72B: 178-188. (Pubitemid 46676750)
8. Sutherland DR, Nayyar R, Acton E, Giftakis A, Dean S, Mosiman VL,. Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACS Calibur and FACS Canto flow cytometers. Cytotherapy 2009; 11: 595-605.
9. Gajkowska A, Oldak T, Jastrzewska M, Machaj EK, Walewski J, Kraszewska E, Pojda Z,. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: A comparison of three methods. Folia Histochemica et Cytobiologica 2006; 44: 53-60. (Pubitemid 43224828)
10. Bender JG, Unverzagt KL, Walker DE, Lee W, Van Epps DE, Smith DH, Stewart CC, To LB,. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991; 77: 2591-2596.
11. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH,. Antigenic analysis of hematopoiesis III.A hematopoetic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells. J Immunol 1984; 133: 157-165. (Pubitemid 14076703)
12. Fu P, Bagai RK, Meyerson H, Kane D, Fox RM, Creger RJ, Cooper BW, Gerson SL, Laughlin MJ, Koc ON, Lazarus HM,. Pre-mobilization of therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization. Bone Marrow Transplant 2006; 38: 189-196. (Pubitemid 44102945)
13. de la Rubia J, Lorenzo JI, Torrabadella M, Marin P, Insunza A, Sanz MA,. Basal CD34+ cell count predicts peripheral blood progenitor cell mobilization and collection in healthy donors after administration of granulocyte colony-stimulating factor. Haematologica 2004; 89: 1530-1532. (Pubitemid 39643525)
14. Menendez P, Redondo O, Rodriguez A, Lopez-Berges MC, Ercilla G, Lopez A, Duran A, Almeida J, Perez-Simon JA, San Miguel JF, Gratama JW, Orfao A,. Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells. Cytometry 1998; 34: 264-271.
15. Lee KE, Mun YC, Nam SH, Kwon JM, Lee SM, Lee MA, Yoo ES, Ahn JY, Kim JH, Seong CM,. A prospective randomized study on the mobilization of CD34+ cells comparing intravenous vs subcutaneous administration of rhG-CSF in normal donors. Bone Marrow Transplant 2005; 12: 1027-1031. (Pubitemid 43078129)
16. Owens M, Loken M,. Flow Cytometry Principles for Clinical Laboratory Practice: Quality Assurance for Quantitative Immunophenotyping. New York, NY: Wiley-Liss; 1995.
17. Terstappen L, Shah V, Civin C, Hurwitz C, Loken M,. Multidimensional flow cytometry as a new approach for discrimination between normal and leukemic cells in peripheral blood and bone marrow. In:, Jansen A, editor. Progress in Cytometry II: Flow and Image. Erembodegen, Belgium: Becton-Dickinson; 1989. pp 4-29.
18. Terstappen LW, Loken MR,. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Anal Cell Pathol 1990; 2: 229-240. (Pubitemid 20185070)
19. Loken M,. Multidimensional data analysis in immunophenotyping. In:, Robinson P, editor. Current Protocols on CD-ROM. New York, NY: Wiley-Liss; 1997.
20. Terstappen LW, Shah VO, Conrad MP, Recktenwald D, Loken MR,. Discriminating between damaged and intact cells in fixed flow cytometric samples. Cytometry 1988; 9: 477-484.
21. Stelzer GT, Shults KE, Loken MR,. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann NY Acad Sci 1993; 677: 265-280. (Pubitemid 23161927)
22. Cesana C, Klersy C, Brando B, Nosari A, Scarpati B, Scampini L, Molteni A, Nador G, Santoleri L, Formenti M, Valentini M, Mazzone A, Morra E, Cairoli R,. Prognostic value of circulating CD34+ cells in myelodysplastic syndromes. Leuk Res 2008; 32: 1715-1723.
23. Passamonti F, Vanelli L, Malabarba L, Rumi E, Pungolino E, Malcovati L, Pascutto C, Morra E, Lazzarino M, Cazzola M,. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. Haematologica 2003; 88: 1123-1129. (Pubitemid 37362544)
24. Lysak D, Koza V, Jindra P,. Factors affecting PBSC mobilization and collection in healthy donors. Transfus Apher Sci 2005; 33: 275-283. (Pubitemid 41586193)
25. Stroncek DF, Clay ME, Petzoldt ML, Smith J, Jaszcz W, Oldham FB, McCullough J,. Treatment of normal individuals with granulocyte-colony- stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996; 36: 601-610. (Pubitemid 26256427)
26. Stroncek DF, Clay ME, Herr G, Smith J, Jaszcz WB, Ilstrup S, McCullough J,. The kinetics of G-CSF mobilization of CD34+ cells in healthy people. Transfus Med 1997; 7: 19-24. (Pubitemid 27141041)
27. Schwinger W, Mache C, Urban C, Beaufort F, Toglhofer W,. Single dose of filgrastim (rhG-CSF) increases the number of hematopoietic progenitors in the peripheral blood of adult volunteers. Bone Marrow Transplant 1993; 11: 489-492. (Pubitemid 23203900)
28. Lubenau H, Bias P, Maly A, Siegler KE, Mehltretter K,. Pharmacokinetic and pharmacodynamic profile of new biosimilar filgrastim XMO2 equivalent to marketed filgrastim Neupogen: Single-blind, randomized, cross-over trial. Biodrugs 2009; 23: 43-51.
29. Okano A, Ashihara E, Shimazaki C, Uchiyama H, Inaba T, Taniguchi K, Maekawa T, Taniwaki M,. Predicitve parameters for granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. J Clin Apheresis 2008; 23: 171-177.